214 related articles for article (PubMed ID: 32351286)
21. Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.
Lin H; Li Q; Liu X; Ma H; Xia M; Wang D; Li X; Wu J; Zhao N; Pan B; Gao X
PLoS One; 2015; 10(10):e0140379. PubMed ID: 26473493
[TBL] [Abstract][Full Text] [Related]
22. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Gong S; Song J; Wang L; Zhang S; Wang Y
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):132-8. PubMed ID: 26545082
[TBL] [Abstract][Full Text] [Related]
23. Liver zonation in children with non-alcoholic fatty liver disease: Associations with dietary fructose and uric acid concentrations.
Nobili V; Mosca A; De Vito R; Raponi M; Scorletti E; Byrne CD
Liver Int; 2018 Jun; 38(6):1102-1109. PubMed ID: 29222961
[TBL] [Abstract][Full Text] [Related]
24. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Zhou Y; Wei F; Fan Y
Clin Biochem; 2016 May; 49(7-8):636-42. PubMed ID: 26738417
[TBL] [Abstract][Full Text] [Related]
25. The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.
Tan Y; Liu X; Zhou K; He X; Lu C; He B; Niu X; Xiao C; Xu G; Bian Z; Zu X; Zhang G; Zhang W; Lu A
PLoS One; 2016; 11(2):e0149043. PubMed ID: 26890003
[TBL] [Abstract][Full Text] [Related]
26. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
[TBL] [Abstract][Full Text] [Related]
27. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
28. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.
Zhang S; Du T; Li M; Lu H; Lin X; Yu X
Medicine (Baltimore); 2017 Mar; 96(12):e6381. PubMed ID: 28328829
[TBL] [Abstract][Full Text] [Related]
29. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.
Mosca A; Nobili V; De Vito R; Crudele A; Scorletti E; Villani A; Alisi A; Byrne CD
J Hepatol; 2017 May; 66(5):1031-1036. PubMed ID: 28214020
[TBL] [Abstract][Full Text] [Related]
30. Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review.
Lădaru A; Bălănescu P; Stan M; Codreanu I; Anca IA
Biomarkers; 2016; 21(2):102-14. PubMed ID: 26632636
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic fatty liver disease: Evolving paradigms.
Lonardo A; Nascimbeni F; Maurantonio M; Marrazzo A; Rinaldi L; Adinolfi LE
World J Gastroenterol; 2017 Sep; 23(36):6571-6592. PubMed ID: 29085206
[TBL] [Abstract][Full Text] [Related]
32. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
Liu CQ; He CM; Chen N; Wang D; Shi X; Liu Y; Zeng X; Yan B; Liu S; Yang S; Li X; Li X; Li Z
Sci Rep; 2016 Dec; 6():38605. PubMed ID: 27924915
[TBL] [Abstract][Full Text] [Related]
33. Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses.
Ma Z; Zhang J; Kang X; Xu C; Sun C; Tao L; Zheng D; Han Y; Li Q; Guo X; Yang X
Atherosclerosis; 2020 Oct; 311():44-51. PubMed ID: 32937242
[TBL] [Abstract][Full Text] [Related]
34. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Vasc Pharmacol; 2011 Nov; 9(6):698-705. PubMed ID: 21388346
[TBL] [Abstract][Full Text] [Related]
35. Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid.
Abbasi S; Haleem N; Jadoon S; Farooq A
J Ayub Med Coll Abbottabad; 2019; 31(1):64-66. PubMed ID: 30868786
[TBL] [Abstract][Full Text] [Related]
36. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
Stål P
World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
[TBL] [Abstract][Full Text] [Related]
37. Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature.
Maida M; Macaluso FS; Salomone F; Petta S
Curr Mol Med; 2016; 16(8):721-737. PubMed ID: 27719652
[TBL] [Abstract][Full Text] [Related]
38. Increased catabolism of nucleic acid in nonalcoholic fatty liver disease patients of different ages.
Tian CR; Qian L; Du CL; Shen XZ
Int J Biol Macromol; 2014 Apr; 65():107-9. PubMed ID: 24456899
[TBL] [Abstract][Full Text] [Related]
39. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.
Sun DQ; Wu SJ; Liu WY; Lu QD; Zhu GQ; Shi KQ; Braddock M; Song D; Zheng MH
Expert Opin Ther Targets; 2016; 20(3):375-87. PubMed ID: 26419119
[TBL] [Abstract][Full Text] [Related]
40. Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
Kim JY; Cho J; Yang HR
J Korean Med Sci; 2018 Apr; 33(16):e122. PubMed ID: 29651819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
